Paragon Care - Public Comps and Valuation Multiples

Paragon Care Overview

About Paragon Care

Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.

Founded

1994

HQ

Employees

Website

paragoncare.com.au

Sectors

Medical Supplies

Financials

LTM Revenue $2.4B

LTM EBITDA $63.9M

EV

$522M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Paragon Care Financials

As of August 2025, Paragon Care reported last 12-month revenue of $2.4B and EBITDA of $63.9M.

In the same period, Paragon Care generated $213M in LTM gross profit and $15.6M in net income.

See Paragon Care valuation multiples based on analyst estimates

Paragon Care P&L

In the most recent fiscal year, Paragon Care reported revenue of $1.9B and EBITDA of $29.3M.

Paragon Care expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Paragon Care valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.4B	XXX	$1.9B	XXX	XXX	XXX
Gross Profit	$213M	XXX	$116M	XXX	XXX	XXX
Gross Margin	9%	XXX	6%	XXX	XXX	XXX
EBITDA	$63.9M	XXX	$29.3M	XXX	XXX	XXX
EBITDA Margin	3%	XXX	2%	XXX	XXX	XXX
EBIT	$46.1M	XXX	$18.6M	XXX	XXX	XXX
EBIT Margin	2%	XXX	1%	XXX	XXX	XXX
Net Profit	$15.6M	XXX	$5.5M	XXX	XXX	XXX
Net Margin	1%	XXX	0%	XXX	XXX	XXX
Net Debt	XXX	XXX	$227M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Paragon Care including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.4B. EBITDA for the last twelve months was $63.9M. In the most recent fiscal year, Paragon Care achieved $1.9B in revenue and $29.3M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.4B	Analyst estimates available to subscribers	$1.9B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$213M	Analyst estimates available to subscribers	$116M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	8.9% gross margin	Analyst estimates available to subscribers	5.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$63.9M	Analyst estimates available to subscribers	$29.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	2.7% EBITDA margin	Analyst estimates available to subscribers	1.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$46.1M	Analyst estimates available to subscribers	$18.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	1.9% EBIT margin	Analyst estimates available to subscribers	1.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$15.6M	Analyst estimates available to subscribers	$5.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	0.7% net profit margin	Analyst estimates available to subscribers	0.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$227M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Paragon Care

This financial data table provides comprehensive performance metrics for Paragon Care, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Paragon Care generated $2.4B in revenue over the last twelve months.
The company achieved $63.9M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $213M.
Net income over the last twelve months reached $15.6M.

Fiscal Year Performance

In the most recent fiscal year, Paragon Care reported $1.9B in total revenue.
Fiscal year EBITDA was $29.3M.
The company maintained a gross profit margin of 5.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 1.5%.
Net profit margin reached 0.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Paragon Care. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Paragon Care Stock Performance

Paragon Care has current market cap of AUD 521M (or $342M), and EV of AUD 796M (or $522M).

Market Cap Evolution

Paragon Care Stock Data

As of September 19, 2025, Paragon Care's stock price is AUD 0 (or $0).

See Paragon Care trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$522M	$342M	XXX	XXX	XXX	XXX	$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Paragon Care Valuation Multiples

Paragon Care's trades at 0.5x EV/Revenue multiple, and 19.5x EV/EBITDA.

See valuation multiples for Paragon Care and 15K+ public comps

Paragon Care Financial Valuation Multiples

As of September 19, 2025, Paragon Care has market cap of $342M and EV of $522M.

Equity research analysts estimate Paragon Care's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Paragon Care has a P/E ratio of 21.9x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$342M	XXX	$342M	XXX	XXX	XXX
EV (current)	$522M	XXX	$522M	XXX	XXX	XXX
EV/Revenue	0.2x	XXX	0.5x	XXX	XXX	XXX
EV/EBITDA	8.2x	XXX	19.5x	XXX	XXX	XXX
EV/EBIT	11.3x	XXX	30.3x	XXX	XXX	XXX
EV/Gross Profit	2.4x	XXX	n/a	XXX	XXX	XXX
P/E	21.9x	XXX	54.5x	XXX	XXX	XXX
EV/FCF	-39.3x	XXX	53.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Paragon Care Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Paragon Care Margins & Growth Rates

Paragon Care's last 12 month revenue growth is 6%

Paragon Care's revenue per employee in the last FY averaged $389M, while opex per employee averaged $19.4M for the same period.

Paragon Care's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Paragon Care's rule of X is 17% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Paragon Care and other 15K+ public comps

Paragon Care Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	6%	XXX	55%	XXX	XXX	XXX
EBITDA Margin	3%	XXX	2%	XXX	XXX	XXX
EBITDA Growth	10%	XXX	63%	XXX	XXX	XXX
Rule of 40	8%	XXX	8%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	17%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$389M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$19.4M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	5%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial